Biotech Stocks Facing FDA Decision In September
27/8 09:08
(RTTNews) - The month of August witnessed the FDA approving the first cell-based gene therapy to treat adult and pediatric patients with beta-thalassemia who require regular blood transfusions on Aug.17. This one-time gene therapy by the name Zynteglo, developed by bluebird bio I...